1-12 of 12
Stavroula Baritaki, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Regulation of Drug Resistance Via the Overexpression of Phopho-RKIP (P-RKIP) in Multiple Myeloma: Dephosphorylation of P-RKIP Reverses Drug Resistance

Devasis Chatterjee, Ph. D, Stavroula Baritaki, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4971.
https://doi.org/10.1182/blood.V130.Suppl_1.4971.4971
Published: 2017
Journal Articles

High Expression of the Resistant Factor YY1 and Low Expression of the RKIP Chemosensitizing Factor in Multiple Myeloma: Delineation of Several Crosstalk Pathways That Regulate the Expression of These Factors

Stephanie Wottrich, Bachelor of Science, Samantha Kaufhold, Bachelor of Science, Stavroula Baritaki, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5417.
https://doi.org/10.1182/blood.V130.Suppl_1.5417.5417
Published: 2017
Journal Articles

The Overexpression of Inactive Phosphorylated Raf-1 Kinase Inhibitory Protein (RKIP) in Multiple Myeloma (MM) Regulates the Resistance to Bortezomib-Induced Cytotoxicity: Reversal of Resistance by the PKC Inhibitor Bisindolylmalemide

Sara Huerta-Yepez, PhD, Stavroula Baritaki, PhD, Hong Liu, Karla MC Mendez-Maldonado, B.S., Manuel L Penichet, M.D., Ph.D., Mario I Vega, PhD, Otoniel Martinez-Maza, PhD, Haiming Chen, James R. Berenson, MD, Devasis Chatterjee, PhD, Benjamin Bonavida, Ph.D
Journal: Blood
Blood (2011) 118 (21): 2892.
https://doi.org/10.1182/blood.V118.21.2892.2892
Published: 2011
Journal Articles

Rituximab Inhibits the PI3K/Akt Survival Pathway In B-NHL Cells Via Induction of the PTEN Tumor Suppressor: Pivotal Roles of the Inhibition of the PTEN Repressors Snail and YY1

Stavroula Baritaki, PhD, Eriko Suzuki, Ph.D, Mario I. Vega, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2010) 116 (21): 3152.
https://doi.org/10.1182/blood.V116.21.3152.3152
Published: 2010
Journal Articles

An ADCC-Independent Mechanism of Rituximab-Mediated B-NHL Cells Depletion Via Sensitization to Cell Death through the Expression of TRAIL on NK Cells

Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Melisa Martinez-Paniagua, BSc, MSc, Stavroula Baritaki, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2010) 116 (21): 4919.
https://doi.org/10.1182/blood.V116.21.4919.4919
Published: 2010
Journal Articles

Reversal of Drug/TRAIL-Resistant B-NHL Cells to Apoptosis by the Combination of Rituximab (anti-CD20) and Either Mapatumumab or Lexatumumab

Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Melisa Martinez-Paniagua, BSc, MSc, Stavroula Baritaki, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2010) 116 (21): 4931.
https://doi.org/10.1182/blood.V116.21.4931.4931
Published: 2010
Journal Articles

Photodynamic Therapy (PDT)-Mediated Inhibition of the Transcription Factor Yin Yang 1 (YY1) That Regulates Resistance In Lymphoma

Valentina Rapozzi, Ph.D, Sara Huerta-Yepez, PhD, Abhijeet Joshi, Mario I. Vega, PhD, Stavroula Baritaki, PhD, Luigi E. Xodo, Ph.D, Benjamin Bonavida, PhD
Journal: Blood
Blood (2010) 116 (21): 5113.
https://doi.org/10.1182/blood.V116.21.5113.5113
Published: 2010
Journal Articles

Mechanism of Obatoclax (GX15-070; Bcl-2 Family Inhibitor)-Induced-Sensitization of B-NHL Cells to TRAIL-Mediated Apoptosis: Inhibition of the NF-κB Survival Pathway and the DR5 Transcription Repressor Yin Yang1 (YY1)

Melisa Martinez- Paniagua, Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Bonilla Gonzalez, PhD, Vanessa Suarez, Stavroula Baritaki, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2008) 112 (11): 4976.
https://doi.org/10.1182/blood.V112.11.4976.4976
Published: 2008
Journal Articles

Identification of Differentially Expressed Genes in the Rituximab- Resistant Clone (Ramos RR1) Compared to Wildtype Sensitive Ramos: Therapeutic Implications in Rituximab-Resistance

Stavroula Baritaki, PhD, Jose Rodriguez, Gustavo Helguera, PhD, Melisa Martinez-Paniagua, Mario Vega, PhD, Sara Huerta-Yepez, PhD., Ali Jazirehi, PhD, Demetrios Spandidos, PhD, Manuel L Penichet, M.D., Ph.D., Benjamin Bonavida, PhD
Journal: Blood
Blood (2008) 112 (11): 3770.
https://doi.org/10.1182/blood.V112.11.3770.3770
Published: 2008
Journal Articles

Rituximab Sensitizes TRAIL-Resistant B-NHL Lines to Apoptosis by Both TRAIL and Fully Humanized Antibodies Targeting TRAIL-R1 (Mapatumumab) and TRAIL-R2 (Lexatumumab).

Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Stavroula Baritaki, PhD, Melisa A. Martinez-Paniagua, McS, Cesar R. Gonzalez-Bonilla, MD, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2007) 110 (11): 2350.
https://doi.org/10.1182/blood.V110.11.2350.2350
Published: 2007
Journal Articles

Nitric Oxide Sensitizes B-NHL Cells to TRAIL-Mediated Apoptosis through Induction of RKIP, Inhibition of YY1 and Upregulation of DR5.

Stavroula Baritaki, PhD, Alina Katsman, Sara Huerta-Yepez, Ph.D., Kam C. Yeung, Ph.D., James Berenson, M.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4604.
https://doi.org/10.1182/blood.V108.11.4604.4604
Published: 2006
Journal Articles

Over Expression of YY1 and RKIP in Multiple Myeloma (Cell Lines and MM Tissues).

Stavroula Baritaki, PhD, Sara Huerta-Yepez, Ph.D., Alina Katsman, Kam C. Yeung, Ph.D., Devasis Chatterjee, Ph.D., Haiming Chen, Ph.D., James Berenson, M.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 5035.
https://doi.org/10.1182/blood.V108.11.5035.5035
Published: 2006